<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although surgery is the gold standard treatment of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastasis</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), many patients ultimately die of their disease </plain></SENT>
<SENT sid="1" pm="."><plain>We tested the hypothesis that the detection of circulating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells (CTC) might identify patients at high risk of dying of disease recurrence after apparently radical liver surgery </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We considered 50 patients undergoing radical surgery for liver-confined <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastasis</z:e> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The expression of a panel of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related genes, as assessed by quantitative real-time PCR, was used to detect CTC in the peripheral blood of these patients immediately before surgery </plain></SENT>
<SENT sid="4" pm="."><plain>Survival analysis was performed by the Cox regression model </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Univariate analysis of the expression levels of CD133 (a marker of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> stem cells) and survivin (an antiapoptotic factor) resulted in statistically significant association with patient survival [hazard ratio (HR) 2.7, 95% confidence interval (CI) 1.9-3.7, P &lt; 0.0001; and hazard ratio 2.1, 95% CI 1.4-3.2, P &lt; 0.0001, respectively] </plain></SENT>
<SENT sid="6" pm="."><plain>Remarkably, multivariate analysis found that only the transcriptional amount of CD133 resulted in statistical significance (HR 2.6, 95% CI 1.9-3.6, P &lt; 0.0001), indicating that this biomarker can independently predict the survival of these patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: CD133-positive CTC may represent a suitable prognostic marker to stratify the risk of patients who undergo liver resection for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, which opens the avenue to identifying and potentially monitoring the patients who are most likely to benefit from adjuvant treatments </plain></SENT>
</text></document>